These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16094085)

  • 21. Glycolipid receptors of F1C fimbrial adhesin of uropathogenic Escherichia coli.
    Khan AS; Hacker J
    Adv Exp Med Biol; 2000; 485():213-7. PubMed ID: 11109108
    [No Abstract]   [Full Text] [Related]  

  • 22. Molecular structure of adhesin domains in Escherichia coli fimbriae.
    Westerlund-Wikström B; Korhonen TK
    Int J Med Microbiol; 2005 Oct; 295(6-7):479-86. PubMed ID: 16238022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Antiadhesive Strategy in Crohn's Disease: Orally Active Mannosides to Decolonize Pathogenic Escherichia coli from the Gut.
    Alvarez Dorta D; Sivignon A; Chalopin T; Dumych TI; Roos G; Bilyy RO; Deniaud D; Krammer EM; de Ruyck J; Lensink MF; Bouckaert J; Barnich N; Gouin SG
    Chembiochem; 2016 May; 17(10):936-52. PubMed ID: 26946458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surface properties of Escherichia coli strains responsible for urinary infections.
    Romano Carratelli C; Nuzzo I; Galdiero M
    Microbiologica; 1987 Jan; 10(1):55-61. PubMed ID: 2883558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Escherichia coli infections.
    Levine MM
    N Engl J Med; 1985 Aug; 313(7):445-7. PubMed ID: 2862583
    [No Abstract]   [Full Text] [Related]  

  • 26. Design, synthesis and biological evaluation of mannosyl triazoles as FimH antagonists.
    Schwardt O; Rabbani S; Hartmann M; Abgottspon D; Wittwer M; Kleeb S; Zalewski A; Smieško M; Cutting B; Ernst B
    Bioorg Med Chem; 2011 Nov; 19(21):6454-73. PubMed ID: 21962988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The tyrosine gate as a potential entropic lever in the receptor-binding site of the bacterial adhesin FimH.
    Wellens A; Lahmann M; Touaibia M; Vaucher J; Oscarson S; Roy R; Remaut H; Bouckaert J
    Biochemistry; 2012 Jun; 51(24):4790-9. PubMed ID: 22657089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding.
    Zhou G; Mo WJ; Sebbel P; Min G; Neubert TA; Glockshuber R; Wu XR; Sun TT; Kong XP
    J Cell Sci; 2001 Nov; 114(Pt 22):4095-103. PubMed ID: 11739641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of adhesion of type 1 fimbriated Escherichia coli to highly mannosylated ligands.
    Nagahori N; Lee RT; Nishimura S; Pagé D; Roy R; Lee YC
    Chembiochem; 2002 Sep; 3(9):836-44. PubMed ID: 12210984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic multimeric heptyl mannosides as potent antiadhesives of uropathogenic Escherichia coli.
    Gouin SG; Wellens A; Bouckaert J; Kovensky J
    ChemMedChem; 2009 May; 4(5):749-55. PubMed ID: 19343765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation and identification of AIDA-I receptors in porcine intestinal mucus.
    Fang Y; Ngeleka M; Middleton DM; Simko E
    Vet Microbiol; 2008 Jan; 126(4):345-55. PubMed ID: 17764859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mannose-derived FimH antagonists: a promising anti-virulence therapeutic strategy for urinary tract infections and Crohn's disease.
    Mydock-McGrane LK; Cusumano ZT; Janetka JW
    Expert Opin Ther Pat; 2016; 26(2):175-97. PubMed ID: 26651364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure and function of Escherichia coli type 1 pili: new insight into the pathogenesis of urinary tract infections.
    Schilling JD; Mulvey MA; Hultgren SJ
    J Infect Dis; 2001 Mar; 183 Suppl 1():S36-40. PubMed ID: 11171011
    [No Abstract]   [Full Text] [Related]  

  • 34. Thiazolylaminomannosides as potent antiadhesives of type 1 piliated Escherichia coli isolated from Crohn's disease patients.
    Brument S; Sivignon A; Dumych TI; Moreau N; Roos G; Guérardel Y; Chalopin T; Deniaud D; Bilyy RO; Darfeuille-Michaud A; Bouckaert J; Gouin SG
    J Med Chem; 2013 Jul; 56(13):5395-406. PubMed ID: 23795713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FimH antagonists: structure-activity and structure-property relationships for biphenyl α-D-mannopyranosides.
    Pang L; Kleeb S; Lemme K; Rabbani S; Scharenberg M; Zalewski A; Schädler F; Schwardt O; Ernst B
    ChemMedChem; 2012 Aug; 7(8):1404-22. PubMed ID: 22644941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microbiology. Pods invade infected bladders.
    Ferber D
    Science; 2003 Jul; 301(5629):31. PubMed ID: 12843366
    [No Abstract]   [Full Text] [Related]  

  • 37. Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli.
    Eto DS; Jones TA; Sundsbak JL; Mulvey MA
    PLoS Pathog; 2007 Jul; 3(7):e100. PubMed ID: 17630833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of potent inhibitors of PapG adhesins from uropathogenic Escherichia coli through synthesis and evaluation of galabiose derivatives.
    Ohlsson J; Jass J; Uhlin BE; Kihlberg J; Nilsson UJ
    Chembiochem; 2002 Aug; 3(8):772-9. PubMed ID: 12203976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fimch antiserum inhibits the adherence of Escherichia coli to cells collected by voided urine specimens of diabetic women.
    Meiland R; Geerlings SE; Langermann S; Brouwer EC; Coenjaerts FE; Hoepelman AI
    J Urol; 2004 Apr; 171(4):1589-93. PubMed ID: 15017227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fimbriae as virulence factors of uropathogenic strains of Escherichia coli].
    Rytlewska M; Liberek A; Sikorska-Wisniewska G; Bako W
    Med Wieku Rozwoj; 2005; 9(4):743-52. PubMed ID: 16733282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.